Does METOPROLOL Cause Supraventricular tachycardia? 132 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Supraventricular tachycardia have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.3% of all adverse event reports for METOPROLOL.
132
Reports of Supraventricular tachycardia with METOPROLOL
0.3%
of all METOPROLOL reports
3
Deaths
66
Hospitalizations
How Dangerous Is Supraventricular tachycardia From METOPROLOL?
Of the 132 reports, 3 (2.3%) resulted in death, 66 (50.0%) required hospitalization, and 10 (7.6%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 132 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
ROSIGLITAZONE (114)
TREPROSTINIL (113)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
PACLITAXEL (86)
Which METOPROLOL Alternatives Have Lower Supraventricular tachycardia Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE